Drug Trial Radar · NCT07322016
A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function
Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
Jan 13, 2026
Primary completion
Aug 4, 2026
Study completion Aug 4, 2026
Sponsor
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 7, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate pharmacokinetics of HRS-1301 tablets in subjects with impaired kidney function in comparison with healthy subjects, to develop dose recommendations for patients with renal impairment.
Conditions
- Hyperlipidemias
Interventions
HRS-1301 TabletDrug
HRS-1301 tablet, oral medication.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum concentration (Cmax).Time frame: 0 hour to 8 days after dosing.
- Area under the concentration-time curve from time zero to the time of the last quantifiable concentration (AUC0-last).Time frame: 0 hour to 8 days after dosing.
- Area under the concentration-time curve from time zero to infinity (AUC0-inf).Time frame: 0 hour to 8 days after dosing.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.